The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade

Biochimie

Volumn 89, Issue 12, 2007, Pages 1544-1552

  Grassi, G ^a   Scaggiante, B ^a   Farra, R ^a   Dapas, B ^a   Agostini, F ^a   Baiz, D ^a   Rosso, N ^b   Tiribelli, C ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Centro Studi Fegato   (Italy)

Author keywords

Apoptosis; Cell cycle; EEF1A1; Hepatic cancer cells EEF1A2

Indexed keywords

ELONGATION FACTOR 1ALPHA; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CELL GROWTH; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, COMPLEMENTARY; GENE AMPLIFICATION; HELA CELLS; HUMANS; LIVER NEOPLASMS; PEPTIDE ELONGATION FACTOR 1; RNA, MESSENGER;

EID: 36248947214     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2007.07.007     Document Type: Article

References (36)

1. Abbott C.M., and Proud C.G. Translation factors: in sickness and in health. Trends Biochem. Sci. 29 (2004) 25-31
2. Lund A., Knudsen S.M., Vissing H., Clark B., and Tommerup N. Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3. Genomics 36 (1996) 359-361
3. Knudsen S.M., Frydenberg J., Clark B.F., and Leffers H. Tissue-dependent variation in the expression of elongation factor-1 alpha isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation-factor 1 alpha. Eur. J. Biochem. 215 (1993) 549-554
4. Condeelis J. Elongation factor 1 alpha, translation and the cytoskeleton. Trends Biochem. Sci. 20 (1995) 169-170
5. Bektas M., Nurten R., Gurel Z., Sayers Z., and Bermek E. Interactions of eukaryotic elongation factor 2 with actin: a possible link between protein synthetic machinery and cytoskeleton. FEBS Lett. 356 (1994) 89-93
6. Gross S.R., and Kinzy T.G. Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology. Nat. Struct. Mol. Biol. 12 (2005) 772-778
7. Lichter P. Multicolor FISHing: what's the catch?. Trends Genet. 13 (1997) 475-479
8. Potter M., Bernstein A., and Lee J.M. The wst gene regulates multiple forms of thymocyte apoptosis. Cell Immunol. 188 (1998) 111-117
9. Talapatra S., Wagner J.D., and Thompson C.B. Elongation factor-1 alpha is a selective regulator of growth factor withdrawal and ER stress-induced apoptosis. Cell Death Differ 9 (2002) 856-861
10. Johnsson A., Zeelenberg I., Min Y., Hilinski J., Berry C., Howell S.B., and Los G. Identification of genes differentially expressed in association with acquired cisplatin resistance. Br. J. Cancer 83 (2000) 1047-1054
11. Cavallius J., Rattan S.I., and Clark B.F. Changes in activity and amount of active elongation factor 1 alpha in aging and immortal human fibroblast cultures. Exp. Gerontol. 21 (1986) 149-157
12. Duttaroy A., Bourbeau D., Wang X.L., and Wang E. Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha. Exp. Cell Res. 238 (1998) 168-176
13. Scaggiante B., Dapas B., Grassi G., and Manzini G. Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell lines. FEBS J 273 (2006) 1350-1361
14. Gangwani L., Mikrut M., Galcheva-Gargova Z., and Davis R.J. Interaction of ZPR1 with translation elongation factor-1alpha in proliferating cells. J. Cell Biol. 143 (1998) 1471-1484
15. Edmonds B.T., Wyckoff J., Yeung Y.G., Wang Y., Stanley E.R., Jones J., Segall J., and Condeelis J. Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J. Cell Sci. 109 Pt 11 (1996) 2705-2714
16. Lee J.M. The role of protein elongation factor eEF1A2 in ovarian cancer. Reprod. Biol. Endocrinol. 1 (2003) 69
17. Anand N., Murthy S., Amann G., Wernick M., Porter L.A., Cukier I.H., Collins C., Gray J.W., Diebold J., Demetrick D.J., and Lee J.M. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet. 31 (2002) 301-305
18. Tanner M.M., Grenman S., Koul A., Johannsson O., Meltzer P., Pejovic T., Borg A., and Isola J.J. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin. Cancer Res. 6 (2000) 1833-1839
19. Hodgson J.G., Chin K., Collins C., and Gray J.W. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res. Treat 78 (2003) 337-345
20. Schlegel J., Stumm G., Scherthan H., Bocker T., Zirngibl H., Ruschoff J., and Hofstadter F. Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res. 55 (1995) 6002-6005
21. de Wit N.J., Burtscher H.J., Weidle U.H., Ruiter D.J., and van Muijen G.N. Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays. Melanoma Res. 12 (2002) 57-69
22. Grant A.G., Flomen R.M., Tizard M.L., and Grant D.A. Differential screening of a human pancreatic adenocarcinoma lambda gt11 expression library has identified increased transcription of elongation factor EF-1 alpha in tumour cells. Int. J. Cancer 50 (1992) 740-745
23. Fujise K., Nagamori S., Hasumura S., Homma S., Sujino H., Matsuura T., Shimizu K., Niiya M., Kameda H., and Fujita K. Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines. Hepatogastroenterology 37 (1990) 457-460
24. Nagamori S., Fujise K., Hasumura S., Homma S., Sujino H., Matsuura T., Shimizu K., Niiya M., and Kameda H. [Protein secretion of human cultured liver cells]. Hum. Cell 1 (1988) 382-390
25. Rothschild M.A., Oratz M., and Schreiber S.S. Albumin synthesis. 1. N. Engl. J. Med. 286 (1972) 748-757
26. Madsen H.O., Poulsen K., Dahl O., Clark B.F., and Hjorth J.P. Retropseudogenes constitute the major part of the human elongation factor 1 alpha gene family. Nucleic Acids Res. 18 (1990) 1513-1516
27. Mansilla F., Hansen L.L., Jakobsen H., Kjeldgaard N.O., Clark B.F., and Knudsen C.R. Deconstructing PTI-1: PTI-1 is a truncated, but not mutated, form of translation elongation factor 1A1, eEF1A1. Biochim. Biophys. Acta 1727 (2005) 116-124
28. Scaggiante B., Morassutti C., Dapas B., Tolazzi G., Ustulin F., and Quadrifoglio F. Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single-stranded DNA-binding proteins. Eur. J. Biochem. 252 (1998) 207-215
29. Grassi G., Schneider A., Engel S., Racchi G., Kandolf R., and Kuhn A. Hammerhead ribozymes targeted against cyclin E and E2F1 co-operate to down regulate coronary smooth muscle cells proliferation. J. Gene Med. 7 (2005) 1223-1234
30. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., and Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92 (1995) 9363-9367
31. Ruest L.B., Marcotte R., and Wang E. Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis. J. Biol. Chem. 277 (2002) 5418-5425
32. Liu X.W., Bernardo M.M., Fridman R., and Kim H.R. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J. Biol. Chem. 278 (2003) 40364-40372
33. Quinn C.M., Kagedal K., Terman A., Stroikin U., Brunk U.T., Jessup W., and Garner B. Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis. Biochem. J. 378 (2004) 753-761
34. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31 (2002) 339-346
35. Munshi R., Kandl K.A., Carr-Schmid A., Whitacre J.L., Adams A.E., and Kinzy T.G. Overexpression of translation elongation factor 1A affects the organization and function of the actin cytoskeleton in yeast. Genetics 157 (2001) 1425-1436
36. Amiri A., Noei F., Jeganathan S., Kulkarni G., Pinke D.E., and Lee J.M. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 26 (2007) 3027-3040